CASC3
Basic information
Region (hg38): 17:40140318-40172183
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CASC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 4 | 0 |
Variants in CASC3
This is a list of pathogenic ClinVar variants found in the CASC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-40140569-G-C | not specified | Uncertain significance (Aug 04, 2023) | ||
17-40140613-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
17-40140618-G-C | not specified | Uncertain significance (Aug 04, 2023) | ||
17-40140624-G-A | not specified | Uncertain significance (May 17, 2023) | ||
17-40140723-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
17-40140747-G-C | not specified | Uncertain significance (Feb 06, 2023) | ||
17-40140769-A-G | not specified | Uncertain significance (Apr 20, 2024) | ||
17-40140772-C-T | not specified | Uncertain significance (Aug 28, 2021) | ||
17-40140775-A-C | not specified | Uncertain significance (Jan 23, 2024) | ||
17-40161817-A-T | not specified | Uncertain significance (Jun 29, 2022) | ||
17-40162087-A-G | not specified | Uncertain significance (Nov 10, 2021) | ||
17-40162736-G-A | not specified | Uncertain significance (Jul 21, 2021) | ||
17-40162804-C-A | not specified | Uncertain significance (Nov 22, 2023) | ||
17-40162856-C-T | not specified | Uncertain significance (Sep 25, 2023) | ||
17-40163542-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
17-40163550-G-C | not specified | Uncertain significance (Mar 28, 2023) | ||
17-40163592-G-C | not specified | Uncertain significance (Sep 17, 2021) | ||
17-40163678-C-T | not specified | Uncertain significance (Oct 06, 2022) | ||
17-40163680-G-A | not specified | Likely benign (Jun 22, 2023) | ||
17-40163707-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
17-40163753-G-A | not specified | Uncertain significance (Dec 14, 2022) | ||
17-40163795-A-G | not specified | Uncertain significance (May 08, 2024) | ||
17-40163921-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
17-40163936-T-C | not specified | Likely benign (Dec 27, 2023) | ||
17-40164011-A-G | not specified | Uncertain significance (Jan 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CASC3 | protein_coding | protein_coding | ENST00000264645 | 13 | 31866 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.613 | 0.387 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.32 | 339 | 414 | 0.818 | 0.0000231 | 4507 |
Missense in Polyphen | 116 | 166.86 | 0.6952 | 1736 | ||
Synonymous | 0.548 | 140 | 148 | 0.943 | 0.00000756 | 1475 |
Loss of Function | 4.52 | 8 | 38.1 | 0.210 | 0.00000239 | 389 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000468 | 0.0000462 |
European (Non-Finnish) | 0.0000890 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). Stimulates the ATPase and RNA- helicase activities of EIF4A3. Plays a role in the stress response by participating in cytoplasmic stress granules assembly and by favoring cell recovery following stress. Component of the dendritic ribonucleoprotein particles (RNPs) in hippocampal neurons. May play a role in mRNA transport. Binds spliced mRNA in sequence-independent manner, 20-24 nucleotides upstream of mRNA exon-exon junctions. Binds poly(G) and poly(U) RNA homopolymer. {ECO:0000269|PubMed:17375189, ECO:0000269|PubMed:17652158}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);RNA transport - Homo sapiens (human);Gene expression (Transcription);RNA Polymerase II Transcription;Metabolism of RNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;Nonsense-Mediated Decay (NMD);Transport of Mature mRNA derived from an Intron-Containing Transcript;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.0981
- rvis_EVS
- -0.89
- rvis_percentile_EVS
- 10.37
Haploinsufficiency Scores
- pHI
- 0.0963
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.563
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Casc3
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;RNA export from nucleus;mRNA export from nucleus;regulation of translation;biological_process;intracellular mRNA localization;mRNA 3'-end processing
- Cellular component
- nucleoplasm;cytosol;cytoplasmic stress granule;nuclear speck;dendrite;nuclear membrane;exon-exon junction complex;perinuclear region of cytoplasm
- Molecular function
- RNA binding;protein binding;enzyme binding;ubiquitin protein ligase binding;identical protein binding